UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Attenuated Psychosis Syndrome: Ready for DSM-5.1?

Annual review of clinical psychology, 2014-01, Vol.10 (1), p.155-192

2014

Volltextzugriff (PDF)

Neuropsychological status of subjects at high risk for a first episode of psychosis

Schizophrenia research, 2004-04, Vol.67 (2), p.115-122

2004

Volltextzugriff (PDF)

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study

Schizophrenia research, 2021-01, Vol.227, p.28-37

2021

Volltextzugriff (PDF)

NAPLS: SOCIAL FUNCTIONING FOUND TO BE A STABLE TRAIT AND A PREDICTOR OF PSYCHOSIS

Schizophrenia research, 2008, Vol.102 (1), p.24-24

2008

Volltextzugriff (PDF)

126 – Persistent drug abuse in first episode psychosis – 1- and 2-year outcome

Schizophrenia research, 2008-02, Vol.98, p.85-85

2008

Volltextzugriff (PDF)

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis

Schizophrenia research, 2019-02, Vol.204, p.334-336

2019

Volltextzugriff (PDF)

Six-year prospective study of major depressive disorder: Remissions, relapses, and the effects of personality disorders

European psychiatry, 2007-03, Vol.22, p.S24-S25

2007

Volltextzugriff (PDF)

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: I. Study rationale and design

Schizophrenia research, 2003-05, Vol.61 (1), p.7-18

2003

Volltextzugriff (PDF)

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: II. Baseline characteristics of the “prodromal” sample

Schizophrenia research, 2003-05, Vol.61 (1), p.19-30

2003

Volltextzugriff (PDF)

Factorial structure of the Scale of Prodromal Symptoms

Schizophrenia research, 2004-06, Vol.68 (2), p.339-347

2004

Volltextzugriff (PDF)

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

Schizophrenia research, 2003-05, Vol.61 (1), p.7-18

2003

Volltextzugriff (PDF)

Abnormal sensory registration, deviance detection, and attention allocation in the schizophrenia prodrome

International journal of psychophysiology, 2008-09, Vol.69 (3), p.186-187

2008

Volltextzugriff (PDF)

0439 FRONTO-TEMPORAL CORTICAL DYSFUNCTION DURING ATTENTION AND WORKING MEMORY FMRI TASKS IN PRODROMAL AND EARLY ILLNESS SCHIZOPHRENIA

Schizophrenia research, 2006-10, Vol.86, p.S76-S76

2006

Volltextzugriff (PDF)

Natural course of schizophrenic illness: Deterioration versus continuation of premorbid function

European neuropsychopharmacology, 1996-06, Vol.6, p.221-221

McGlashan, T.H.

1996

Volltextzugriff (PDF)

The borderline personality disorder practice guidelines: the good, the bad, and the realistic

Journal of personality disorders, 2002-04, Vol.16 (2), p.119-121

McGlashan, T H

2002

Volltextzugriff (PDF)

WC8A THE CRITERIA OF PRODROMAL SYNDROMES AND ALTERNATE PRODROMAL DIAGNOSTIC CRITERIA IN NAPLS

Schizophrenia research, 2006-10, Vol.86, p.S17-S17

2006

Volltextzugriff (PDF)

Diagnosis and symptom assessment in the schizophrenia prodrome

Schizophrenia research, 2003-03, Vol.60 (1), p.6-7

2003

Volltextzugriff (PDF)

Neurocognitive dimensions characterizing first-time psychotic patients

European psychiatry, 2002-05, Vol.17, p.54-54

2002

Volltextzugriff (PDF)

Natural history of the deficit syndrome

Schizophrenia research, 1993-04, Vol.9 (2), p.98-98

1993

Volltextzugriff (PDF)

Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results

Schizophrenia research, 2003-03, Vol.60 (1), p.295-295

2003

Volltextzugriff (PDF)

Olanzapine versus placebo for prodromal symptoms

Schizophrenia research, 2003-03, Vol.60 (1), p.306-307

2003

Volltextzugriff (PDF)

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

Schizophrenia research, 2003-05, Vol.61 (1), p.19-30

2003

Volltextzugriff (PDF)

Testing systems for assessment of negative symptoms in schizophrenia

Schizophrenia research, 1991-05, Vol.4 (3), p.256-256

1991

Volltextzugriff (PDF)

Spontaneous dyskinesia in schizophrenia

Schizophrenia research, 1995-04, Vol.15 (1), p.207-207

1995

Volltextzugriff (PDF)

A neural network computer simulation of normal speech perception and hallucinated ‘voices’

Schizophrenia research, 1993-04, Vol.9 (2), p.178-178

1993

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Psychiatry
(10)
Humans
(8)
Life Sciences & Biomedicine
(7)
Science & Technology
(7)
Schizophrenia
(6)
Adolescent
(5)
Adult
(5)
Female
(5)
Male
(5)
Psychosis
(5)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Psychology. Psychoanalysis. Psychiatry
(4)
Prevention
(3)
Prodromal Symptoms
(3)
Psychopathology. Psychiatry
(3)
Psychotic Disorders - Diagnosis
(3)
Psychotic Disorders - Epidemiology
(3)
Schizophrenic Psychology
(3)
Antipsychotic Agents - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(28)
Elsevier ScienceDirect Journals Complete
(28)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(25)
MEDLINE
(8)
EZB-FREE-00999 freely available EZB journals
(3)
IngentaConnect Journals
(1)
Guilford Periodicals Online
(1)
Journals@Ovid
(0)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Attenuated Psychosis Syndrome: Ready for DSM-5.1?

Neuropsychological status of subjects at high risk for a first episode of psychosis

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study

NAPLS: SOCIAL FUNCTIONING FOUND TO BE A STABLE TRAIT AND A PREDICTOR OF PSYCHOSIS

126 – Persistent drug abuse in first episode psychosis – 1- and 2-year outcome

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis

Six-year prospective study of major depressive disorder: Remissions, relapses, and the effects of personality disorders

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: I. Study rationale and design

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: II. Baseline characteristics of the “prodromal” sample

Factorial structure of the Scale of Prodromal Symptoms

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

Abnormal sensory registration, deviance detection, and attention allocation in the schizophrenia prodrome

0439 FRONTO-TEMPORAL CORTICAL DYSFUNCTION DURING ATTENTION AND WORKING MEMORY FMRI TASKS IN PRODROMAL AND EARLY ILLNESS SCHIZOPHRENIA

Natural course of schizophrenic illness: Deterioration versus continuation of premorbid function

The borderline personality disorder practice guidelines: the good, the bad, and the realistic

WC8A THE CRITERIA OF PRODROMAL SYNDROMES AND ALTERNATE PRODROMAL DIAGNOSTIC CRITERIA IN NAPLS

Diagnosis and symptom assessment in the schizophrenia prodrome

Neurocognitive dimensions characterizing first-time psychotic patients

Natural history of the deficit syndrome

Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results

Olanzapine versus placebo for prodromal symptoms

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

Testing systems for assessment of negative symptoms in schizophrenia

Spontaneous dyskinesia in schizophrenia

A neural network computer simulation of normal speech perception and hallucinated ‘voices’

Aktive Filter

Suchergebnisse filtern